The Health March/April 2024 | Page 25

March-April . 2024 | The HEALTH

People

25

Pioneering robotic surgery in oncology

MALAYSIAN-BORN Dr Zhi Ven Fong a Surgical Oncologist at Mayo Clinic Arizona , recently made headlines for spearheading the firstever robotic Whipple surgery at the medical institution . This ground-breaking procedure marks a significant advancement in the field of surgical oncology , particularly in the treatment of pancreatic cancer .

Dr Fong ’ s journey to the forefront of robotic surgery is as remarkable as his groundbreaking achievements . Born and raised in Kuala Lumpur , he began his medical career at the International Medical University before pursuing further studies at Jefferson Medical College in Philadelphia , USA .
He later completed his residency in General Surgery at Massachusetts General Hospital and a fellowship in Complex General Surgical Oncology at Dana Farber Cancer Institute , Mass General Brigham . Joining the staff at Mayo Clinic Arizona as an Asst Prof , Dr Fong has emerged as a trailblazer in surgical oncology .
Working in close collaboration with a multidisciplinary team of physicians , he devises
comprehensive treatment plans tailored to the individual needs of patients with gastric and hepatopancreatic biliary tumours . His expertise extends to integrating minimally invasive techniques , including laparoscopic and robotic approaches , in managing complex malignancies .
BENEFITS OF ROBOTIC SURGERY
The Whipple procedure , a complex surgery aimed at addressing tumours and ailments affecting the pancreas , small intestine , and bile ducts , is notorious for its invasiveness and challenging recovery process . Traditionally , surgeons navigate through a labyrinth of abdominal organs to access the pancreas , often resulting in prolonged hospital stays and post-operative complications .
However , Dr Fong ’ s innovative approach harnesses the power of robotics to revolutionise this intricate procedure . Dr Fong and his team can perform the Whipple surgery with unprecedented precision and efficiency by utilising state-of-the-art robotic technology .
The surgeon operates a console , controlling a robotic arm with a joystick-like interface reminiscent of a video game to execute the
Dr Fong guides the robot ' s arms during a total robotic Whipple surgery .
delicate manoeuvres required for the surgery .
The benefits of robotic surgery are manifold . Not only does it enable smaller incisions and reduced invasiveness compared to traditional methods , but it also translates to shorter recovery times and decreased risk of complications such as hernias .
Patients undergoing robotic Whipple surgery experience improved post-operative outcomes , paving the way for a more streamlined and patient-centric approach to pancreatic cancer treatment .
As the leader of Mayo Clinic Arizona ’ s robotic pancreas surgery programme , Dr Fong continues to push the boundaries of innovation in surgical oncology . With the adoption of robotic technology on the rise , his legacy underscores the transformative impact of innovation in healthcare delivery , offering hope to countless patients battling pancreatic cancer and other complex diseases .

Malaysian scientist gets RM11.3 million for innovative breast cancer research

AN Assoc Prof at the University of Nottingham Malaysia ’ s ( UNM ) Faculty of Science and Engineering , Dr Ho Weang Kee , has secured a prestigious Wellcome Trust Career Development Award ( WTCDA ) of £ 1.92 million ( RM11.3 million ) to develop novel breast cancer risk stratification and communication methods in diverse Asian populations .
The Wellcome Trust , a renowned UK-based charitable foundation established in 1936 , is dedicated to funding research to advance scientific discoveries across various domains to enhance human life , health , and well-being . Dr Ho ’ s achievement underscores her potential as a leading figure in international research .
In collaboration with the UNM and Cancer Research Malaysia ( CRM ), Dr Ho will spearhead an eight-year research programme to refine breast cancer risk assessment models specific to Asian populations . Her innovative approach aims to bridge existing research gaps by leveraging advanced statistical techniques to extract valuable insights from underrepresented datasets .
Dr Ho said : “ The aim of this eight-year research programme is two-fold : to develop and apply advanced statistical techniques to harness the value of existing , less powerful datasets to build disease risk prediction models for under-represented populations and to extract disease risk-associated medical imaging features to enable visualisation of risk .
“ The plan is to start with breast cancer and expand to other non-communicable diseases in the future .
“ This research programme is rooted in the foundational work of the Malaysian Breast Cancer Genetics Studies , the largest breast
Dr Ho Weang Kee cancer study in Malaysia established by CRM .
“ Supported by a collaborative network of partners from the UK , US , Singapore , and our home base in Malaysia , alongside our esteemed members of the Healthier Lives Research Cluster ( HLRC ) at UNM , we have laid a robust foundation for our ongoing research initiatives .
“ I am confident that this award will empower us to strengthen these collaborations further , engaging with a diverse range of stakeholders to determine the most effective strategies for disease control in our region ,” said Dr Ho , also the co-director of HLRC .
CRM Chief Scientific Officer Datin Paduka Prof Dr Teo Soo-Hwang , commended Dr Ho ’ s leadership .
“ This award recognises Dr Ho ’ s scientific brilliance and the impact of her leadership on cancer research .
“ Dr Ho has already led pivotal studies on genetics in Asian breast cancers and advanced our understanding of how to accurately predict risk and how to use this information to ensure appropriate screening strategies in Asians .”
Send subscription to Revon Media Sdn Bhd A-5-1 , Parklane Commercial Hub , Jalan SS 7 / 26 , SS 7 , 47301 Petaling Jaya , Selangor D . E ., Malaysia . Tel : + 603-7886 6091